secwatch.observer — SEC 8-K summary
======================================

Issuer:     Cyclerion Therapeutics, Inc. (CYCN)
CIK:        0001755237
Form:       8-K
Filed at:   2023-11-24T23:59:59+00:00
Accession:  0001193125-23-282705
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Director Ole Isacson resigns from Cyclerion board; replacement to be named
--------------------------------------------------------------------------

- Ole Isacson, M.D., Ph.D., resigned as director effective November 19, 2023.
- He served as Chair of Compensation Committee and member of Audit Committee.
- No disagreement with Cyclerion on operations, policies, or practices.
- Company expects to appoint a new outside director shortly.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1755237/000119312523282705/0001193125-23-282705-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1755237/000119312523282705/d600226d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-282705

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer